Author Archives: admin


Dr. Andreas Sauerbrey: The right orthopaedic diagnosis is essential to proper care – Steamboat Pilot and Today

Dr. Andreas Sauerbrey believes the most important factor in getting efficient and correct orthopaedic treatment is having the right diagnosis.

You need to come to a specialist who can give you the options for that diagnosis, he said.

Dr. Sauerbrey, who specializes in shoulder and upper-extremity surgery, sports medicine, and joint restoration at Steamboat Orthopaedic and Spine Institute (SOSI), is proud of the access the institute provides to so many fellowship-trained surgeons. This extra level of training and experience provides the community with orthopaedic care that is truly world class.

When you come to see us, youll get the right diagnosis, but it doesnt mean you have to have surgery, he said.

Shoulder, elbow and hand

Dr. Sauerbrey is fellowship trained in shoulder and elbow surgery from the University of Pennsylvania and in hand surgery from Thomas Jefferson University in Philadelphia. He also holds a Sports Medicine Specialty Certificate.

Dr. Sauerbrey is particularly skilled in shoulder arthroscopy and reconstruction, and biologic treatments such as platelet-rich plasma (PRP) and growth factors.

For the past 20 years, Dr. Sauerbrey has performed 300 to 400 shoulder surgeries annually. He does just about every orthopaedic procedure, including knee and hip replacements, but about 60% of his work focuses on shoulders.

People have options within our practice, he said. If they dont come see me, they should see one of my partners. Theres really no reason to go out of town.

A progressive approach

Dr. Sauerbrey has been performing PRP injections since 2008. Hes particularly enthusiastic about how biomedicine has evolved in orthopaedic medicine during that time.

The biggest changes in orthopaedic medicine have been in biologics its just blown up in the last 10 years, he said.

Dr. Sauerbrey works with some of the most advanced orthopaedic companies to deliver the latest methods and treatments, which include PRP and stem cells.

The companies we use are very progressive, surgeon-driven, constantly innovating, he says. Its remarkable how much is out there, and SOSI offers it all.

PRP, the most popular injection, releases growth factors that trick the body into creating a healing response. Dr. Sauerbrey says he frequently does PRP injections in knees, shoulders and elbows. While its not going to fix mechanical injuries (such as an ACL tear), PRP, when used in the right context, can relieve pain and improve mobility.

My intention is to bring state-of-the-art medicine to Steamboat in an efficient and affordable way, he said. Together, we ensure the latest, most innovative technology available for both operative and non-operative procedures. We believe patients and their families should have the best care possible at all times.

Destined for orthopaedics

Dr. Sauerbreys brain was always mechanically oriented, so its no surprise he chose a medical field that would allow him to practice that skill on the human body.

Being good with your hands you either have it or you dont, he said. For me, it probably goes back to the days of wrenching on cars with my dad.

One of the first major decisions that medical students make about their future careers is whether they will become surgeons. For Sauerbrey, that happened by his second year of medical school. Having a mother who worked as an orthopaedic nurse for 20 years and getting the mechanical practice he did while working with his father, Sauerbrey was practically destined to become an orthopaedic surgeon.

I knew I had to do procedures, he said. Once you decide that, it eliminates half the field of potential specialties.

Community driven

With a belief that good health care should never be hard to find, Dr. Sauerbrey has committed himself to building an orthopaedic practice that puts the community first. Most of the SOSI physicians have been practicing in Yampa Valley for many years, and thats a testament to their high quality of care.

You cannot survive in a community like this if youre not doing a good job its not going to happen, he says. Youre operating on your friends and neighbors, and you have to be comfortable with that.

With an extremely active and motivated population that demands to be fixed back up so that they can return to their beloved outdoor activities, theres a real motivation to help patients get through their injuries and come out stronger on the other side.

We fix people so they can go back to what they love, Dr. Sauerbrey said. Were accountable socially here in Steamboat.

See more here:
Dr. Andreas Sauerbrey: The right orthopaedic diagnosis is essential to proper care - Steamboat Pilot and Today

Induced Pluripotent Stem Cells Market to Witness Huge Growth by 2025| Bone Therapeutics SA, System Biosciences, Axiogenesis, Regeneus Ltd.,…

The Induced Pluripotent Stem Cells Market Research Report aims to provide insights that strongly demonstrate the market structure, scope, history, potential, and development perspective. By crossing through the historical and present market status, the Induced Pluripotent Stem Cells market report provides authentic and reliable estimates for the forecast period. The Best part of this report is, this analyses the current state where all are fighting with the COVID-19, The report also provides the market impact and new opportunities created due to the Covid19 catastrophe.

It became essential to distinguish the saturation of consumption in the Induced Pluripotent Stem Cells market owing to building competitiveness. Hence, the report furnishes a deep-felt market segmentation analysis based on several segments such as types, applications, regions, and end-users. It serves to precisely target the actual market size and product and service needs of customers. It also helps industry companies in promoting products that completely meet emerging customer needs.

Collect sample copy of the Induced Pluripotent Stem Cells market research at: https://www.amplemarketreports.com/sample-request/covid-19-outbreak-global-induced-pluripotent-stem-cells-industry-1913462.html

The report furnishes the analysis of market encounter, segmentation, leading market players, industry environment, and microeconomic factors that help clients, Induced Pluripotent Stem Cells companies, investors, officials, and researchers perceive ongoing market performance within a minute. The report also reveals in-depth details of shifting market dynamics, pricing structures, trends, restraints, limitations, demand-supply variations, growth-boosting factors, and market variations that have been considered the most important factors in the Induced Pluripotent Stem Cells market.

Comprehensive analysis of Induced Pluripotent Stem Cells market segment by manufactures:

The report also highlights its financial position by assessing gross margin, profitability, production cost, pricing structure, expenses, Induced Pluripotent Stem Cells sales volume, revenue, and growth rate. Their raw material sourcing strategies, organizational structure, corporate alliance, Induced Pluripotent Stem Cells production volume, manufacturing base, sales areas, distribution network, global presence, product specifications, effective technologies, major vendors, and import-export activities are also emphasized in this report.

The report includes profound importance for the individuals/companies operating and financing in the Induced Pluripotent Stem Cells market as Bone Therapeutics SA, System Biosciences, Axiogenesis, Regeneus Ltd., Cellectics, CellTherapies P/L, Cellular Dynamics, Reprocell, BrainStorm Cell Therapeutics Inc., Iperian, Stemgent, Fate Therapeutics, Viacyte, Lonza, Organogenesis Inc., Waisman Biomanufacturing, Ocata Therapeutics Inc., Medipost Co. Ltd., it holds helpful insights that immediate to discover and interpret market demand, market size, share, and rivalry sitch. The report incorporates comprehensive market intelligence procured using both qualitative and quantitative research methods. It also contracts proficient systematic analytical studies including Porters Five Forces, SWOT analysis, and Probability analysis to review the market thoroughly.

Find out more about competitive landscape at: https://www.amplemarketreports.com/report/covid-19-outbreak-global-induced-pluripotent-stem-cells-industry-1913462.html

The report moreover presents a comprehensive representation of Induced Pluripotent Stem Cells manufacturers and companies who have been attempting to pose their dominance in the market in terms of sales, revenue, and growth. The report traverses their applications such as product research, development, innovation, and technology appropriation which supports them to deliver more efficient product lineup in the industry. Profitable business plans, including acquiring, mergers, ventures, amalgamations, as well as product launches, and brand promotions are also elucidating in the report.

Comprehensive analysis of Induced Pluripotent Stem Cells market segment Type, Application:

Furthermore, it explores various requisite segments of the global Induced Pluripotent Stem Cells market such as types, applications, regions, and technologies. The report grants a comprehensive analysis of each market acknowledging market acceptance, attractiveness, demand, production, and predicted sales revenue by Type(Adult Sources, Fetal Sources, Others) and by Application(Hematopoietic stem cell transplantation, Tissue repair damage, Autoimmune diseases, As gene therapy vectors). The segmentation analysis helps consumers to select suitable segments for their Induced Pluripotent Stem Cells business and specifically target the wants and needs of their existing and potential customer base.

Comprehensive analysis of Induced Pluripotent Stem Cells market segment by Regional Analysis:

The report focuses on regional coverage across the globe principally with respect to x-x Units, revenue (Million USD), market share and growth rate variable within each region depending upon its capacity. Regions that have been covered for this market included North America (Covered in Chapter 7 and 14), United States, Canada, Mexico, Europe (Covered in Chapter 8 and 14), Germany, UK, France, Italy, Spain, Russia

Discount, Know more this research report at: https://www.amplemarketreports.com/discount-request/covid-19-outbreak-global-induced-pluripotent-stem-cells-industry-1913462.html

Thanks for reading this article, you can also get individual chapter wise section or region wise report versions like North America, Western / Eastern Europe or Southeast Asia.

With the given market data, Research on Global Markets offers customizations according to specific needs.

About Author

Ample Market Research provides comprehensive market research services and solutions across various industry verticals and helps businesses perform exceptionally well. Our end goal is to provide quality market research and consulting services to customers and add maximum value to businesses worldwide. We desire to deliver reports that have the perfect concoction of useful data. Our mission is to capture every aspect of the market and offer businesses a document that makes solid grounds for crucial decision making.

Contact Address:

William James

Media & Marketing Manager

Address: 3680 Wilshire Blvd, Ste P04 1387 Los Angeles, CA 90010

Call: +1 (530) 868 6979

Email: [emailprotected]

https://www.amplemarketreports.com

See more here:
Induced Pluripotent Stem Cells Market to Witness Huge Growth by 2025| Bone Therapeutics SA, System Biosciences, Axiogenesis, Regeneus Ltd.,...

Keros Therapeutics Presents Results from Preclinical Studies Investigating KER-012 at the American Society for Bone and Mineral Research 2020 Annual…

LEXINGTON, Mass., Sept. 11, 2020 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today announced results from preclinical studies of KER-012 at the American Society for Bone and Mineral Research (ASBMR) 2020 Annual Meeting Virtual Event held September 11-15, 2020.

Excerpt from:
Keros Therapeutics Presents Results from Preclinical Studies Investigating KER-012 at the American Society for Bone and Mineral Research 2020 Annual...

Adamas Announces New Employment Inducement Grant

EMERYVILLE, Calif., Sept. 11, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted two new employees the option to purchase an aggregate of 269,250 shares of the company’s common stock, at a per share exercise price of $5.12, the closing trading price on September 8, and restricted stock units to acquire 2,125 shares of the company’s common stock. The stock options and restricted stock units vest over four years and were granted pursuant to the Adamas Pharmaceuticals, Inc. 2016 Inducement Plan, which was approved by the company's board of directors in March 2016 under Rule 5653(c)(4) of the Nasdaq Global Market for equity grants to induce new employees to enter into employment with the company.

Read more:
Adamas Announces New Employment Inducement Grant

AnaptysBio to Present at the 2020 Cantor Global Virtual Healthcare Conference

SAN DIEGO, Sept. 11, 2020 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today announced that Hamza Suria, chief executive officer of AnaptysBio, will present at the 2020 Cantor Global Virtual Healthcare Conference on Thursday, September 17, 2020 at 12:00 p.m. ET. The conference will be conducted virtually, and the presentation will be available via https://www.webcaster4.com/Webcast/Page/2495/37348

Read more:
AnaptysBio to Present at the 2020 Cantor Global Virtual Healthcare Conference

Avadel to Present at H.C. Wainwright 22nd Annual Global Investment Conference

DUBLIN, Ireland, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL) a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate, today announced that its executive team will be presenting at the H.C. Wainwright 22nd Annual Global Investment Conference taking place September 14 – 16, 2020.

Read more here:
Avadel to Present at H.C. Wainwright 22nd Annual Global Investment Conference